Company intelligence / Profile preview

Jiangzhong Pharmaceutical

Nanchang, Jiangxi, Chinahongguangxiang.com ↗

Ownership: Private
Employees: ~4182
Development stage: Commercial

Overview

Jiangzhong Pharmaceutical has several approved drugs on the market, including both traditional Chinese medicines and small molecule pharmaceuticals. Its portfolio includes treatments for pharyngitis, anesthesia, common cold, and inflammatory bowel diseases. The company also develops health foods and functional foods. Some programs are in preclinical or Phase 2 stages; most key assets are already commercialized in China.

Therapeutic areas: OtherGastroenterologyInfectious Diseases
Modalities: Herbal medicineSmall molecule drugProbiotics
Industry: Biotech

Drug pipeline

5 assets

Shen Ling Gu Ben

Preclinical

4 more assets in the full pipeline.

Request access →

Partnerships

Synergy with Haisi Pharmaceutical after acquisition by parent company

Beyond the preview

Go deeper on Jiangzhong Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangzhong Pharmaceutical.

Explore the full profile